CASE REPORT
Atypical IgA-associated vasculitis – case reports
 
More details
Hide details
1
Department of Paediatrics, Immunology, and Nephrology, Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland
 
2
Department of Paediatrics, Preventive Cardiology and Immunology of Developmental Age, Medical University of Lodz, Poland
 
3
Division of Didactics in Paediatrics, Medical University of Lodz, Poland
 
 
Submission date: 2019-12-19
 
 
Final revision date: 2020-02-23
 
 
Acceptance date: 2020-03-21
 
 
Publication date: 2020-03-31
 
 
Pediatr Pol 2020;95(1):56-60
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
IgA-associated vasculitis (IgA vasculitis, IgAV), formerly known as Henoch-Schönlein purpura, is the most common systemic inflammation of the small vessels in children. The disease most often affects the skin, joints, digestive tract and kidneys. It is usually characterised by a mild and self-limiting course and full recovery within a few weeks. The paper presents the cases of patients with severe and complicated IgAV.

Case report:
In both cases, the kidneys were affected by the disease. The first patient had rare necrotic skin changes and splenic infarction not previously described. The second patient developed hypertension and nephropathy with nephrotic proteinuria.

Conclusions:
IgA-associated vasculitis can have a severe course and produce rare complications. Patients may require non-standard individualised management as well as long-term clinical observation to monitor renal function parameters and complications of the treatment.
REFERENCES (11)
1.
Wiatr E, Gawryluk D. [Primary systemic ANCA-associated vasculitis--recommendations concerning diagnosis and treatment]. Pneumonol Alergol Pol 2013; 81: 479-491.
 
2.
KDIGO Clinical Practice Guidelines for Glomerulonephritis. Kidney Int Suppl 2012; 2: 218-220.
 
3.
Paller A, M Mancini A. Hurwitz Clinical Pediatric Dermatology. A Textbook of Skin Disorders of Childhood and Adolescence. 5th ed. Elsevier; 2016: 495-498.
 
4.
Garland JS, Chusid MJ. Henoch-Schönlein purpura: association with unusual vesicular lesions. Wis Med J 1985; 84: 21-23.
 
5.
Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999; 78: 395-409.
 
6.
Den Boer SL, Pasmans S, Wulffraat NM, et al. Bullous lesions in Henoch Schonlein Purpura as indication to start systemic prednisone. Acta Paediatr 2010; 99: 781-783.
 
7.
McCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of Henoch-Schonlein purpura. Eur J Pediatr 2010; 169: 643-650.
 
8.
Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90: 916-920.
 
9.
Pohl M. Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2015; 30: 245-252.
 
10.
Ozen S, Marks SD, Brogan P, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019; 58: 1607-1616.
 
11.
Huong DL, Gatfosse M, Papo T, et al. Symptomatic splenic infarction complicating adult Kawasaki disease. Br J Rheumatol 1995; 34: 579-580.
 
Journals System - logo
Scroll to top